These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 34852086)

  • 21. SARS-CoV-2 vaccines, where do we stand?
    Fischer A
    C R Biol; 2021 Jun; 344(1):43-55. PubMed ID: 34213848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing COVID-19 in Brazil: fragmented efforts and challenges to expand diagnostic capacity at the Brazilian Unified National Health System.
    Kameda K; Barbeitas MM; Caetano R; Löwy I; Oliveira ACD; Corrêa MCDV; Cassier M
    Cad Saude Publica; 2021; 37(3):e00277420. PubMed ID: 33852667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects.
    Wheeler SE; Shurin GV; Yost M; Anderson A; Pinto L; Wells A; Shurin MR
    Microbiol Spectr; 2021 Sep; 9(1):e0034121. PubMed ID: 34346750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to Immunization: Rebuttal of Vaccine Hesitancy.
    Etzioni-Friedman T; Etzioni A
    Acta Haematol; 2021; 144(4):413-417. PubMed ID: 33202404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccine Strategy During the SARS-CoV-2 Pandemic: What School Nurses Need to Know.
    Barnby E; Reynolds M; Gordon J
    NASN Sch Nurse; 2021 Nov; 36(6):316-322. PubMed ID: 34060925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding perception and acceptance of Sinopharm vaccine and vaccination against COVID-19 in the UAE.
    Ahamed F; Ganesan S; James A; Zaher WA
    BMC Public Health; 2021 Aug; 21(1):1602. PubMed ID: 34461846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.
    Tostanoski LH; Gralinski LE; Martinez DR; Schaefer A; Mahrokhian SH; Li Z; Nampanya F; Wan H; Yu J; Chang A; Liu J; McMahan K; Ventura JD; Dinnon KH; Leist SR; Baric RS; Barouch DH
    J Virol; 2021 Nov; 95(23):e0097421. PubMed ID: 34523968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silent Consequences of COVID-19: Why It's Critical to Recover Routine Vaccination Rates Through Equitable Vaccine Policies and Practices.
    Skolnik A; Bhatti A; Larson A; Mitrovich R
    Ann Fam Med; 2021; 19(6):527-531. PubMed ID: 34376387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Brazilian National Immunization Program: 46 years of achievements and challenges.
    Domingues CMAS; Maranhão AGK; Teixeira AM; Fantinato FFS; Domingues RAS
    Cad Saude Publica; 2020; 36Suppl 2(Suppl 2):e00222919. PubMed ID: 33111749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic.
    Sharun K; Dhama K
    Arch Med Res; 2021 Oct; 52(7):761-763. PubMed ID: 33941393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparing the public for COVID-19 vaccines: How can general practitioners build vaccine confidence and optimise uptake for themselves and their patients?
    Danchin M; Biezen R; Manski-Nankervis JA; Kaufman J; Leask J
    Aust J Gen Pract; 2020 Oct; 49(10):625-629. PubMed ID: 33015676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
    Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
    MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The politics of COVID-19 vaccination in middle-income countries: Lessons from Brazil.
    Fonseca EMD; Shadlen KC; Bastos FI
    Soc Sci Med; 2021 Jul; 281():114093. PubMed ID: 34144480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
    Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
    J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes of the Public Attitudes of China to Domestic COVID-19 Vaccination After the Vaccines Were Approved: A Semantic Network and Sentiment Analysis Based on Sina Weibo Texts.
    Gao H; Guo D; Wu J; Zhao Q; Li L
    Front Public Health; 2021; 9():723015. PubMed ID: 34858918
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of a Codebook of Online Anti-Vaccination Rhetoric to Manage COVID-19 Vaccine Misinformation.
    Hughes B; Miller-Idriss C; Piltch-Loeb R; Goldberg B; White K; Criezis M; Savoia E
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Offering onsite COVID-19 vaccination to high-risk obstetrical patients: initial findings.
    Hirshberg JS; Huysman BC; Oakes MC; Cater EB; Odibo AO; Raghuraman N; Kelly JC
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100478. PubMed ID: 34481996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Promoting influenza vaccination during 2021-2022 season from the perspective of population medicine].
    Feng LZ; Wang Q; Yang WZ
    Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(46):3771-3774. PubMed ID: 34895415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.